Clarification of Optimal Anticoagulation Through Genetics (COAG)

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00839657
First received: February 6, 2009
Last updated: April 19, 2016
Last verified: May 2013